The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.

The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief ...

Immediate symptomatic relief and long-term neuroimmunomodulation seen with acupressure combined with pharmacotherapy ...

HealthDay News — The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study published online September 29 in The Lancet Diabetes & ...

HealthDay News — Quadrivalent human papillomavirus (HPV) vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth, according to a study ...

Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.

Vanda Pharmaceuticals has paused the clinical program for VQW-765 after a phase 3 trial evaluating the drug for social anxiety disorder failed to show significant distress reduction compared with ...

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

Protein (sodium and calcium caseinates, L-arginine), carbohydrate (corn syrup, fructose), fat (high oleic sunflower, MCT, corn oils), L-carnitine, taurine, vitamins ...

Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...